Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| 908 Devices Inc. | 895,559 | reported | 28 May 2026 | tx 71+366,029−436,559 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | SALE | 908 Devices Inc. | 30,000 | 9.00 USD | 10b5-1 |
| 06 May 2026 | SALE | 908 Devices Inc. | 20,000 | 7.23 USD | 10b5-1 |
| 01 Feb 2026 | EXERCISE | 908 Devices Inc. | 10,992 | — | |
| 01 Feb 2026 | EXERCISE | 908 Devices Inc. | 7,418 | — | |
| 01 Feb 2026 | EXERCISE | 908 Devices Inc. | 5,027 | — | |
| 01 Feb 2026 | EXERCISE | 908 Devices Inc. | 10,992 | 0.00 USD | deriv |
| 01 Feb 2026 | EXERCISE | 908 Devices Inc. | 7,418 | 0.00 USD | deriv |
| 01 Feb 2026 | EXERCISE | 908 Devices Inc. | 5,027 | 0.00 USD | deriv |
| 03 Feb 2025 | SALE | 908 Devices Inc. | 2,459 | 2.34 USD | |
| 01 Feb 2025 | EXERCISE | 908 Devices Inc. | 5,027 | — | |
| 03 Feb 2025 | SALE | 908 Devices Inc. | 3,641 | 2.33 USD | |
| 01 Feb 2025 | EXERCISE | 908 Devices Inc. | 7,418 | — | |
| 03 Feb 2025 | SALE | 908 Devices Inc. | 1,667 | 2.36 USD | |
| 01 Feb 2025 | EXERCISE | 908 Devices Inc. | 10,991 | — | |
| 01 Feb 2025 | EXERCISE | 908 Devices Inc. | 10,991 | 0.00 USD | deriv |
| 01 Feb 2025 | EXERCISE | 908 Devices Inc. | 7,418 | 0.00 USD | deriv |
| 01 Feb 2025 | EXERCISE | 908 Devices Inc. | 5,027 | 0.00 USD | deriv |
| 19 Dec 2024 | EXERCISE | 908 Devices Inc. | 55,131 | 1.58 USD | |
| 19 Dec 2024 | EXERCISE | 908 Devices Inc. | 55,131 | 0.00 USD | deriv |
| 07 Aug 2024 | EXERCISE | 908 Devices Inc. | 6,328 | 1.58 USD | |
| 07 Aug 2024 | EXERCISE | 908 Devices Inc. | 6,328 | 0.00 USD | deriv |
| 01 Apr 2024 | EXERCISE | 908 Devices Inc. | 3,600 | 1.75 USD | |
| 01 Apr 2024 | EXERCISE | 908 Devices Inc. | 3,600 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | 908 Devices Inc. | 43,965 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | 908 Devices Inc. | 60,064 | 0.00 USD | deriv |